Biocept Inc (BIOCQ)

[THREE-DAY-TRADER]

This company is it's own worst enemy. Around January 2018 they crashed their stock with Share offering news to raise money, then they do it soon again in May recently with an S-3 filing, & then quickly follow that up now in May with the R/S proposal at their upcoming shareholder meeting June 28.

However, with so many awful things recently already being priced into the stock including the R/S proposal, it might still have hope in the short term for a trade from sub .20 levels.
The R/S proposal authorization vote isn't until the shareholder meeting June 28, and still it's only an authorization if it's approved with a date & ratio eventually to be declared later down the road at their convenience.
Between now and the next couple or few months, this stock could have a big rally yet if it gets any news whatsoever as it is technical very-very beat down (oversold).

That said, I wouldn't blame anyone to fear this stock given the risks in front of it, but I wouldn't totally count it out either (as explained above).